DSB 2005 Program
Quantitative Genomics Workshop
Workshop Session 1
Michael Pfaffl, Technical University, Munich: Quantification of gene expression by real-time qRT-PCR
Kristina Warton, Corbett Research, Sydney: Improvements to RNA extraction from formaldehyde fixed tissues
Mark Jones, University of Western Sydney: Applications of Direct Real Time PCR on Lymphocytes.
Keith Stanley, Corbett Research, Sydney: Highly multiplexed SyBr green qPCR of breast cancer genes
Workshop Session 2
Paul Pilowsky, University of Sydney: Quantitation of neurotransmitter-related gene expression in the brain stem.
Brant Bassam, Corbett Research, Melbourne: Assay Design for Real-Time PCR
Valin Reja, Corbett Research, Sydney: High resolution melt analysis
Peter Williamson, University of Sydney: The use of Real-Time PCR in a comparative genomics Programme
Panel Discussion - Chair: Keith Stanley
Session 3: Victorian Proteomics Consortia Proteomics Session - Sponsored by: IIRD, Victorian State Government
Ruedi Aebersold, Institute for Systems Biology, Vancouver, Canada:
Quantitative Proteomics and Systems Biology
Kevin Downard, University of Sydney: Flu takes flight: Influenza surveillance by mass spectrometry
Jeff Gorman, IMB, Queensland: Multidimensional Mass Spectrometric Analyses of Regulatory Post-Translational Modifications of Proteins
Anthony Purcell, Bio21 Molecular Science and Biotechnology Institute, Melbourne: Antigen post-translational modification – insights into the targets of the elusive autoreactive T cell!
Session 4: Immunology
Chris Goodnow, APF, JCSMR, Canberra: Controlled variation of the mammalian genome: the rosetta stone for decoding genome - phenome programming
Jose Varghese, CSIRO: In silico screening of drug targets and the Australian Synchrotron
Session 5: Biotechnology drivers & Commercialisation
David Blake, BIMA, Melbourne: Biotech drivers
Rowan Gilmore, Australian Institute for Commercialisation: The Road from Discovery to Market
Richard Wettenhall, Bio21 Molecular Sciences and Biotechnology Institute, Melbourne: Integrating research innovation, commercialisation and industry engagement in the new Bio21 Institute
Silviu Itescu, Columbia University, NY : Commercialisation of adult stem cells
Session 6: Genome wide studies and Systems Biology
Malcolm McConnville, Bio21 Molecular Sciences and Biotechnology Institute, Melbourne: Metabolomics and the Identification of new metabolic pathways in human pathogens
Peter Hunter, Bioengineering Institute, University of Auckland: Multiscale modelling and the Physiome Project
Sean Grimmond, IMB, University of Queensland: Computational and genomic characterization of signal transduction networks
Session 7: Neurobiology
Seth Grant, Wellcome Trust Sanger Institute, Hinxton, Cambridge: From Genes to Cognition
Colin Masters, The University of Melbourne: Pathways towards drug development in Alzheimer's disease
Phil Robinson, Children's Medical Research Institute, Sydney: Mass Spectrometry Approaches to Phosphorylation Sites in Endocytic Proteins at the Synapse
Session 8: Gene expression and knockdown
Andrew Holloway, Peter MacCallum Cancer Centre, Melbourne:
A systematic analysis of microarray platform accuracy
Greg Arndt, Johnson & Johnson Research:
Gene knockdown using long complimentary RNAs
Nick Dean, ISIS, California : Antisense approaches to gene therapy
Session 9: Cancer
Thomas Schmittgen, College of Pharmacy Ohio State University: Real-time expression profiling of microRNAs in cancer
Michelle Haber, Children's Cancer Institute Australia for Medical Research: Childhood neuroblastoma: From target identification and validation through to drug discovery
Robin Anderson, Peter MacCallum Cancer Centre, Melbourne: A search for the genes that regulate breast cancer metastasis
Alex Dobrovic, Peter MacCallum Cancer Centre, Melbourne: Towards pharmaco-epigenomics: profiling DNA repair in cancer cell lines using high throughput quantitative RT-PCR
Conference Committee
May 4-6, 2005, Rydges Melbourne Hotel, Australia
Convenor Co-Convenor Committee |
Program Committee
|